Your browser doesn't support javascript.
loading
How prostate-specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway.
Ptasznik, Gideon; Kelly, Brian D; Murphy, Declan; Lawrentschuk, Nathan; Kasivisvanathan, Veeru; Page, Mark; Ong, Sean; Moon, Daniel.
Afiliación
  • Ptasznik G; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Kelly BD; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Murphy D; Young Urology Research Organisation, Melbourne, VIC, Australia.
  • Lawrentschuk N; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Kasivisvanathan V; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Page M; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Ong S; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Moon D; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
BJU Int ; 133 Suppl 3: 13-14, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37691457

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: BJU Int Asunto de la revista: UROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: BJU Int Asunto de la revista: UROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Australia